US FDA seeks stakeholder feedback on draft guidance on tablet scoring
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has issued for comment draft guidance on criteria that sponsors of drug marketing applications should meet to facilitate the evaluation and labelling of tablets that are scored to make them easier to split into smaller portions 1,2.